Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amino acid peritoneal dialysis solution and residual renal function in PD patients
ChiCTR2500105428Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2025
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of amino acid peritoneal dialysis solution in end-stage kidney disease (ESKD) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Residual renal function and Estimated glomerular filtration rate (eGFR). Planned start Jul 2025; status: not yet recruiting.
02
Drugs
amino acid peritoneal dialysis solution
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR2500105428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105428.